MX2015007794A - Suministro transmucosal de acetato de glatiramer mediante parches orales. - Google Patents

Suministro transmucosal de acetato de glatiramer mediante parches orales.

Info

Publication number
MX2015007794A
MX2015007794A MX2015007794A MX2015007794A MX2015007794A MX 2015007794 A MX2015007794 A MX 2015007794A MX 2015007794 A MX2015007794 A MX 2015007794A MX 2015007794 A MX2015007794 A MX 2015007794A MX 2015007794 A MX2015007794 A MX 2015007794A
Authority
MX
Mexico
Prior art keywords
glatiramer acetate
transmucosal delivery
oral transmucosal
percent
film composition
Prior art date
Application number
MX2015007794A
Other languages
English (en)
Spanish (es)
Inventor
Ursula Geister
Stephan Schweizer
Martina Buerger
Ralph Stefan
Gerald Huber
Tanja Pries
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of MX2015007794A publication Critical patent/MX2015007794A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX2015007794A 2012-12-21 2013-12-20 Suministro transmucosal de acetato de glatiramer mediante parches orales. MX2015007794A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261745243P 2012-12-21 2012-12-21
PCT/US2013/077041 WO2014100643A1 (en) 2012-12-21 2013-12-20 Oral transmucosal delivery of glatiramer acetate

Publications (1)

Publication Number Publication Date
MX2015007794A true MX2015007794A (es) 2015-09-04

Family

ID=50979258

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015007794A MX2015007794A (es) 2012-12-21 2013-12-20 Suministro transmucosal de acetato de glatiramer mediante parches orales.

Country Status (15)

Country Link
US (1) US20150328277A1 (cg-RX-API-DMAC7.html)
EP (1) EP2934493A4 (cg-RX-API-DMAC7.html)
JP (1) JP2016503066A (cg-RX-API-DMAC7.html)
KR (1) KR20150111919A (cg-RX-API-DMAC7.html)
CN (1) CN104869984A (cg-RX-API-DMAC7.html)
AU (1) AU2013361057A1 (cg-RX-API-DMAC7.html)
BR (1) BR112015014092A2 (cg-RX-API-DMAC7.html)
CA (1) CA2895457A1 (cg-RX-API-DMAC7.html)
EA (1) EA201591187A1 (cg-RX-API-DMAC7.html)
HK (2) HK1214522A1 (cg-RX-API-DMAC7.html)
IL (1) IL239279A0 (cg-RX-API-DMAC7.html)
MX (1) MX2015007794A (cg-RX-API-DMAC7.html)
SG (1) SG11201504461QA (cg-RX-API-DMAC7.html)
WO (1) WO2014100643A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201505050B (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA025780B1 (ru) 2010-10-11 2017-01-30 Тева Фармасьютикал Индастриз Лтд. Цитокиновые биомаркеры в качестве биомаркеров, прогнозирующих клинический ответ на глатирамер ацетат
MX2014004309A (es) 2011-10-10 2015-07-06 Teva Pharma Polimorfismos de nucleotidos individuales utiles para predecir una respuesta clinica para el acetato de glatiramer.
UY35790A (es) 2013-10-21 2015-05-29 Teva Pharma Marcadores genéticos que predicen la respuesta al acetato de glatiramer
US10493122B2 (en) 2014-03-17 2019-12-03 Mapi Pharma Ltd. Sublingual delivery of glatiramer acetate
US10323289B2 (en) 2017-06-26 2019-06-18 Institut Pasteur Treatments to eliminate HIV reservoirs and reduce viral load

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0679002A (ja) * 1993-12-14 1994-03-22 Hisamitsu Pharmaceut Co Inc 経皮投与用パッチシステム
US6197331B1 (en) * 1997-07-24 2001-03-06 Perio Products Ltd. Pharmaceutical oral patch for controlled release of pharmaceutical agents in the oral cavity
US7022663B2 (en) * 2000-02-18 2006-04-04 Yeda Research And Development Co., Ltd. Oral, nasal and pulmonary dosage formulations of copolymer 1
US20020077278A1 (en) * 2000-06-05 2002-06-20 Yong V. Wee Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders
US20030175328A1 (en) * 2002-03-06 2003-09-18 Adi Shefer Patch for the controlled delivery of cosmetic, dermatological, and pharmaceutical active ingredients into the skin
NZ540318A (en) * 2002-10-31 2007-09-28 Umd Inc Therapeutic compositions for drug delivery to and through covering epithelia
EP2106790B1 (en) * 2004-03-12 2012-10-24 Biodel, Inc. Rapid acting drug delivery compositions
FI20041425A0 (fi) * 2004-11-05 2004-11-05 Orion Corp Transmukosaalinen veterinäärinen koostumus
US20060205822A1 (en) * 2004-12-22 2006-09-14 Forest Laboratories, Inc. 1-Aminocyclohexane derivatives for the treatment of multiple sclerosis, emotional lability and pseudobulbar affect
US20060210616A1 (en) * 2005-03-17 2006-09-21 Linder Barry J Therapeutic patch for ophthalmologic and cosmetic use
US20070021325A1 (en) * 2005-07-21 2007-01-25 Mediplex Corporation Drug formulation containing a solubilizer for enhancing solubility, absorption, and permeability
US20080027011A1 (en) * 2005-12-20 2008-01-31 Hassan Nached Homogeneous paste and gel formulations
KR100809404B1 (ko) * 2005-12-28 2008-03-05 (주)스피어테크 리포좀화 시킨 나노용매를 함유하는 경피흡수 점착시트형 화장료 조성물 및 제조방법
WO2007087188A2 (en) * 2006-01-20 2007-08-02 Merck & Co., Inc. Taste-masked tablets and granules
RU2436565C2 (ru) * 2006-02-17 2011-12-20 Новартис Аг Распадающиеся пероральные пленки
WO2008006226A1 (en) * 2006-07-14 2008-01-17 Wine, Harvey Transdermal formulations of synthetic cannabinoids and nano colloidal silica
AU2007329375A1 (en) * 2006-12-04 2008-06-12 The Board Of Trustees Of The University Of Illinois Compositions and methods to treat cancer with cupredoxins and CpG rich DNA
JP5177447B2 (ja) * 2007-06-07 2013-04-03 佐藤製薬株式会社 速溶性及び可撓性を有するフィルム製剤
WO2009005814A2 (en) * 2007-07-03 2009-01-08 Marchitto Kevin S Drug-delivery patch comprising a dissolvable layer and uses thereof
US20100278899A1 (en) * 2007-12-06 2010-11-04 Lintec Corporation Edible film

Also Published As

Publication number Publication date
WO2014100643A1 (en) 2014-06-26
JP2016503066A (ja) 2016-02-01
ZA201505050B (en) 2016-10-26
CN104869984A (zh) 2015-08-26
SG11201504461QA (en) 2015-07-30
HK1214522A1 (zh) 2016-07-29
WO2014100643A8 (en) 2015-06-25
EP2934493A4 (en) 2016-09-07
HK1214133A1 (zh) 2016-07-22
EP2934493A1 (en) 2015-10-28
EA201591187A1 (ru) 2016-03-31
CA2895457A1 (en) 2014-06-26
US20150328277A1 (en) 2015-11-19
AU2013361057A1 (en) 2015-07-30
BR112015014092A2 (pt) 2017-07-11
KR20150111919A (ko) 2015-10-06
IL239279A0 (en) 2015-07-30

Similar Documents

Publication Publication Date Title
MX2013002422A (es) Sales de lorcaserina con acidos opticamente activos.
JOP20180102A1 (ar) مركب صيدلاني
MY173521A (en) Trpv4 antagonists
PH12014501351A1 (en) Fluorinated estrogen receptor modulators and uses thereof
PH12013501136A1 (en) Lysophosphatidic acid receptor antagonists and uses thereof
SG10201907588XA (en) Androgen Receptor Modulators And Uses Thereof
MX366090B (es) Combinación farmacéutica para usarse en mejorar la tolerancia a la glucosa en pacientes que padecen diabetes de tipo 2.
EA201590805A1 (ru) Композиция с немедленным и пролонгированным высвобождением
MY161406A (en) Stabilization of zinc oxide film in oral compositions
PE20141906A1 (es) Esketamina para el tratamiento de la depresion refractaria al tratamiento o resistente al tratamiento
UA98839C2 (en) N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
PH12012501522A1 (en) Oral care compositions
MX2013004981A (es) Composiciones y metodos para la administracion de agentes terapeuticos.
PH12012501620A1 (en) Oral care compositions
MY179497A (en) Beta-casein a2 and prevention of inflammation of the bowel
IN2013DN02552A (cg-RX-API-DMAC7.html)
PH12014502571A1 (en) Ophthalmic compositions with improved dessication protection and retention
MX2015007678A (es) Liberacion transmucosa de acetato de glatiramero por medio de tabletas orales.
HK1214522A1 (zh) 醋酸格拉默的口腔透黏膜给药
MX2016007546A (es) Composiciones para el cuidado oral anti-mal olor.
AR084224A1 (es) Composicion de relleno que comprende grano integral hidrolizado
EP2611799A4 (en) PHARMACEUTICAL COMPOSITIONS OF LINEZOLID
MX2014006201A (es) Formas de dosificaciones solidas de imatinib reconstituidas justo antes de usarse.
TR201109158A2 (tr) Eplerenon içeren kolay çözünebilen farmasötik kompozisyon.
TN2011000352A1 (en) New combination of active ingredients containing a non steroidal anti inflammatory drug and a colchicoside derivative